Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis.

Prior research has shown that Staphylococcus aureus interacts with host cells through surface receptors, but the specific mechanisms of platelet binding remain unclear. While some studies have explored bacterial adhesion to platelets, the role of surface carbohydrates and immune receptors has not been fully resolved. Established knowledge includes the general understanding that platelets can bind bacteria, but the extent and variability across S. aureus strains are less defined. No prior work had resolved how different treatments, such as proteases or monoclonal antibodies, affect binding dynamics. This gap motivated the need to quantify binding under controlled conditions. That uncertainty drove the use of flow cytometry to measure binding percentages across multiple isolates. Researchers have not yet determined whether receptor-ligand interactions are reversible or saturable in this context. This study addresses these unresolved questions.

The aim of this study was to characterize the binding of S. aureus to platelets using quantitative flow cytometry. The specific problem addressed is the variability in binding percentages among different strains and the influence of various treatments on this interaction. Researchers sought to determine whether binding is saturable and reversible, as these properties suggest receptor-ligand interactions. The motivation for this work stems from the need to understand the molecular mechanisms underlying platelet-bacterial adhesion. Previous studies lacked detailed quantification of binding under different experimental conditions. This paper contributes by providing strain-specific data on binding percentages and the effects of modifiers. The study also tests whether platelet Fc receptors play a role in binding. These findings could inform future investigations into bacterial pathogenesis.

The study used flow cytometry to quantify S. aureus binding to platelets after various treatments. Treatments included proteases like trypsin and protease K, antibiotics such as oxacillin and gentamicin, and surface carbohydrate modifiers like sodium periodate. Platelets were also exposed to a monoclonal antibody targeting the Fc gamma RII receptor. Binding percentages were measured for multiple S. aureus isolates. The experimental design tested how each modifier affected binding efficiency. Researchers used homologous and heterologous anticapsular antibodies to assess specificity. Platelet microbicidal protein was applied to evaluate its impact on binding. Data collection focused on statistical significance and variability across strains.

Binding percentages varied significantly among S. aureus isolates, ranging from 22.1% to 76.4%. The binding process was rapid, saturable, and reversible, indicating receptor-ligand interactions. Platelet microbicidal protein reduced binding by 32.1% (P < 0.001). Homologous anticapsular antibody decreased binding by 17.7% (P < 0.05). Sodium periodate reduced binding by 36.3% (P < 0.005). Anti-platelet Fc monoclonal antibody decreased binding by 41.5% (P < 0.002). These results suggest that multiple mechanisms contribute to binding. The data highlight the role of carbohydrate-rich ligands and Fc receptors in platelet interactions.

The authors propose that S. aureus-platelet binding involves multiple mechanisms. The findings suggest that binding is mediated by carbohydrate-rich surface ligands and platelet microbicidal protein-susceptible components. The Fc receptor on platelets also appears to play a role in this interaction. The study supports the idea that binding is saturable and reversible, consistent with receptor-ligand dynamics. No single factor was identified as essential for binding. The data indicate that different isolates exhibit variable binding efficiencies. Researchers suggest that these mechanisms may contribute to bacterial pathogenesis. The study does not propose new drug targets or future directions beyond these observations.